|
A recent report from Institut Curie suggests that after the introduction of adjuvant trastuzumab, the recurrence rates at that institution among women with subcentimeter, HER2 positive breast cancers plummeted <a href=https://stromectol.mom>stromectol pharmacy</a> |
|
转播